JPH0460988B2 - - Google Patents
Info
- Publication number
- JPH0460988B2 JPH0460988B2 JP10405882A JP10405882A JPH0460988B2 JP H0460988 B2 JPH0460988 B2 JP H0460988B2 JP 10405882 A JP10405882 A JP 10405882A JP 10405882 A JP10405882 A JP 10405882A JP H0460988 B2 JPH0460988 B2 JP H0460988B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- parts
- lower alkyl
- formula
- aminocarbonyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001875 compounds Chemical class 0.000 claims description 98
- 125000000217 alkyl group Chemical group 0.000 claims description 61
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 54
- 238000000034 method Methods 0.000 claims description 48
- -1 cyano, amino Chemical group 0.000 claims description 39
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 38
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 34
- 239000001257 hydrogen Substances 0.000 claims description 34
- 229910052739 hydrogen Inorganic materials 0.000 claims description 34
- 238000006243 chemical reaction Methods 0.000 claims description 32
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims description 30
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 28
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 26
- 239000002253 acid Substances 0.000 claims description 24
- 150000003839 salts Chemical class 0.000 claims description 23
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 18
- 125000005843 halogen group Chemical group 0.000 claims description 18
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 18
- 125000003118 aryl group Chemical group 0.000 claims description 16
- 150000001412 amines Chemical class 0.000 claims description 15
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims description 13
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 12
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims description 10
- VNRJGEMERJZKLQ-UHFFFAOYSA-N 2-piperazin-1-ylacetamide Chemical compound NC(=O)CN1CCNCC1 VNRJGEMERJZKLQ-UHFFFAOYSA-N 0.000 claims description 9
- 125000003545 alkoxy group Chemical group 0.000 claims description 9
- 125000005129 aryl carbonyl group Chemical group 0.000 claims description 9
- 239000003153 chemical reaction reagent Substances 0.000 claims description 9
- 208000028867 ischemia Diseases 0.000 claims description 9
- 239000002904 solvent Substances 0.000 claims description 9
- 229910021529 ammonia Inorganic materials 0.000 claims description 8
- 239000002585 base Substances 0.000 claims description 7
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 7
- 239000012442 inert solvent Substances 0.000 claims description 7
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 7
- 239000008194 pharmaceutical composition Substances 0.000 claims description 7
- 206010021143 Hypoxia Diseases 0.000 claims description 6
- 150000001350 alkyl halides Chemical class 0.000 claims description 6
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 6
- 125000000524 functional group Chemical group 0.000 claims description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 6
- 125000001424 substituent group Chemical group 0.000 claims description 6
- 230000002378 acidificating effect Effects 0.000 claims description 5
- 125000004104 aryloxy group Chemical group 0.000 claims description 5
- 150000002431 hydrogen Chemical class 0.000 claims description 5
- 239000002609 medium Substances 0.000 claims description 5
- BSJWIZFCTFMJGT-UHFFFAOYSA-N 1-[4,4-bis(4-fluorophenyl)butyl]piperazine-2-carboxamide Chemical compound NC(=O)C1CNCCN1CCCC(C=1C=CC(F)=CC=1)C1=CC=C(F)C=C1 BSJWIZFCTFMJGT-UHFFFAOYSA-N 0.000 claims description 4
- 125000001769 aryl amino group Chemical group 0.000 claims description 4
- 125000004391 aryl sulfonyl group Chemical group 0.000 claims description 4
- 230000000747 cardiac effect Effects 0.000 claims description 4
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 4
- 125000001624 naphthyl group Chemical group 0.000 claims description 4
- 125000004076 pyridyl group Chemical group 0.000 claims description 4
- 125000001544 thienyl group Chemical group 0.000 claims description 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 4
- 206010002660 Anoxia Diseases 0.000 claims description 3
- 241000976983 Anoxia Species 0.000 claims description 3
- 239000003513 alkali Substances 0.000 claims description 3
- 230000007953 anoxia Effects 0.000 claims description 3
- 239000012736 aqueous medium Substances 0.000 claims description 3
- 230000008081 blood perfusion Effects 0.000 claims description 3
- 230000007954 hypoxia Effects 0.000 claims description 3
- 239000002841 Lewis acid Substances 0.000 claims description 2
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 claims description 2
- 239000012458 free base Substances 0.000 claims description 2
- 150000007517 lewis acids Chemical class 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 229910052987 metal hydride Inorganic materials 0.000 claims description 2
- 150000004681 metal hydrides Chemical class 0.000 claims description 2
- 210000004165 myocardium Anatomy 0.000 claims description 2
- 231100000252 nontoxic Toxicity 0.000 claims description 2
- 230000003000 nontoxic effect Effects 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 13
- CUJPFPXNDSIBPG-UHFFFAOYSA-N 1,3-propanediyl Chemical group [CH2]C[CH2] CUJPFPXNDSIBPG-UHFFFAOYSA-N 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000000543 intermediate Substances 0.000 description 125
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 123
- 239000000203 mixture Substances 0.000 description 97
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 83
- 239000000047 product Substances 0.000 description 69
- 239000000243 solution Substances 0.000 description 64
- 238000002844 melting Methods 0.000 description 63
- 230000008018 melting Effects 0.000 description 63
- 239000003480 eluent Substances 0.000 description 54
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 48
- 239000011541 reaction mixture Substances 0.000 description 45
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 41
- 238000003756 stirring Methods 0.000 description 40
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 39
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 38
- 229960001701 chloroform Drugs 0.000 description 38
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 30
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 29
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 28
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 28
- 238000004440 column chromatography Methods 0.000 description 28
- 239000000741 silica gel Substances 0.000 description 28
- 229910002027 silica gel Inorganic materials 0.000 description 28
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 27
- 239000003054 catalyst Substances 0.000 description 27
- 239000007788 liquid Substances 0.000 description 26
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 24
- 238000001816 cooling Methods 0.000 description 22
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 21
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 21
- 239000000284 extract Substances 0.000 description 19
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 17
- 239000004480 active ingredient Substances 0.000 description 17
- 238000007126 N-alkylation reaction Methods 0.000 description 16
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 15
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 14
- 229910000029 sodium carbonate Inorganic materials 0.000 description 14
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 12
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- 239000012074 organic phase Substances 0.000 description 12
- 239000007858 starting material Substances 0.000 description 12
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 11
- 238000010992 reflux Methods 0.000 description 11
- 238000010438 heat treatment Methods 0.000 description 10
- 239000007787 solid Substances 0.000 description 10
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 9
- 241000282472 Canis lupus familiaris Species 0.000 description 8
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 8
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 8
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 8
- 239000008346 aqueous phase Substances 0.000 description 8
- 238000005984 hydrogenation reaction Methods 0.000 description 8
- 150000004885 piperazines Chemical class 0.000 description 8
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 238000010586 diagram Methods 0.000 description 7
- 150000002148 esters Chemical class 0.000 description 7
- 125000006239 protecting group Chemical group 0.000 description 7
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric Acid Chemical compound [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 6
- 230000029936 alkylation Effects 0.000 description 6
- 238000005804 alkylation reaction Methods 0.000 description 6
- 150000001408 amides Chemical class 0.000 description 6
- 238000009835 boiling Methods 0.000 description 6
- 210000003748 coronary sinus Anatomy 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 6
- 239000012258 stirred mixture Substances 0.000 description 6
- 239000003826 tablet Substances 0.000 description 6
- 229930192474 thiophene Natural products 0.000 description 6
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 5
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 5
- 229960000583 acetic acid Drugs 0.000 description 5
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 5
- 125000004432 carbon atom Chemical group C* 0.000 description 5
- 238000002425 crystallisation Methods 0.000 description 5
- 230000008025 crystallization Effects 0.000 description 5
- 239000003937 drug carrier Substances 0.000 description 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 5
- 239000005457 ice water Substances 0.000 description 5
- 238000001990 intravenous administration Methods 0.000 description 5
- 239000003208 petroleum Substances 0.000 description 5
- 125000004193 piperazinyl group Chemical group 0.000 description 5
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Inorganic materials [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- OZMORHVDUHRQLL-UHFFFAOYSA-N 1-fluoro-4-[1-(4-fluorophenyl)-4-iodobutyl]benzene Chemical compound C1=CC(F)=CC=C1C(CCCI)C1=CC=C(F)C=C1 OZMORHVDUHRQLL-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- MFESCIUQSIBMSM-UHFFFAOYSA-N I-BCP Chemical compound ClCCCBr MFESCIUQSIBMSM-UHFFFAOYSA-N 0.000 description 4
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 125000003158 alcohol group Chemical group 0.000 description 4
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 4
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 230000002612 cardiopulmonary effect Effects 0.000 description 4
- 239000003610 charcoal Substances 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 125000002346 iodo group Chemical group I* 0.000 description 4
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- 239000012312 sodium hydride Substances 0.000 description 4
- 229910000104 sodium hydride Inorganic materials 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 239000000440 bentonite Substances 0.000 description 3
- 229910000278 bentonite Inorganic materials 0.000 description 3
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 125000001246 bromo group Chemical group Br* 0.000 description 3
- 125000001309 chloro group Chemical group Cl* 0.000 description 3
- 210000001105 femoral artery Anatomy 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 3
- PYLWMHQQBFSUBP-UHFFFAOYSA-N monofluorobenzene Chemical compound FC1=CC=CC=C1 PYLWMHQQBFSUBP-UHFFFAOYSA-N 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000012299 nitrogen atmosphere Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 3
- 229960003415 propylparaben Drugs 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 230000008707 rearrangement Effects 0.000 description 3
- 238000006268 reductive amination reaction Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 238000001665 trituration Methods 0.000 description 3
- PRPGZLYWOJPAQZ-UHFFFAOYSA-N (4-fluorophenyl)-[2-(hydroxymethyl)phenyl]methanol Chemical compound OCC1=CC=CC=C1C(O)C1=CC=C(F)C=C1 PRPGZLYWOJPAQZ-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- BVCJSDGVJGPPLY-UHFFFAOYSA-N 1,4-dibenzyl-2-(methoxymethyl)piperazine Chemical compound C1CN(CC=2C=CC=CC=2)C(COC)CN1CC1=CC=CC=C1 BVCJSDGVJGPPLY-UHFFFAOYSA-N 0.000 description 2
- UFBBMJWPPBNTGA-UHFFFAOYSA-N 1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran Chemical compound C1=CC(F)=CC=C1C1C2=CC=CC=C2CO1 UFBBMJWPPBNTGA-UHFFFAOYSA-N 0.000 description 2
- IMEJYFCEYZLALP-UHFFFAOYSA-N 1-[4,4-bis(4-fluorophenyl)butyl]-2-(methoxymethyl)piperazine Chemical compound COCC1CNCCN1CCCC(C=1C=CC(F)=CC=1)C1=CC=C(F)C=C1 IMEJYFCEYZLALP-UHFFFAOYSA-N 0.000 description 2
- ZVBLTWFIHCNRKJ-UHFFFAOYSA-N 1-[4-benzyl-2-(methoxymethyl)piperazin-1-yl]-2,2,2-trifluoroethanone Chemical compound C1CN(C(=O)C(F)(F)F)C(COC)CN1CC1=CC=CC=C1 ZVBLTWFIHCNRKJ-UHFFFAOYSA-N 0.000 description 2
- UXXLTPGCINZEFM-UHFFFAOYSA-N 1-[4-chloro-1-(4-fluorophenyl)butyl]-4-fluorobenzene Chemical compound C1=CC(F)=CC=C1C(CCCCl)C1=CC=C(F)C=C1 UXXLTPGCINZEFM-UHFFFAOYSA-N 0.000 description 2
- KEKZCXPIPPSFDE-UHFFFAOYSA-N 1-benzyl-3-(methoxymethyl)piperazine Chemical compound C1CNC(COC)CN1CC1=CC=CC=C1 KEKZCXPIPPSFDE-UHFFFAOYSA-N 0.000 description 2
- BMDBKYIQYZZARN-UHFFFAOYSA-N 2,2,2-trifluoro-1-[2-(methoxymethyl)piperazin-1-yl]ethanone Chemical compound COCC1CNCCN1C(=O)C(F)(F)F BMDBKYIQYZZARN-UHFFFAOYSA-N 0.000 description 2
- JPKIYKWSYBYKIS-UHFFFAOYSA-N 2,2-bis(4-fluorophenyl)acetonitrile Chemical compound C1=CC(F)=CC=C1C(C#N)C1=CC=C(F)C=C1 JPKIYKWSYBYKIS-UHFFFAOYSA-N 0.000 description 2
- JMQGXDAAZNTETE-UHFFFAOYSA-N 2-(3,3-dimethyl-5,6,8,8a-tetrahydro-1h-[1,3]oxazolo[3,4-a]pyrazin-7-yl)-n-(5-fluoro-2-methylphenyl)acetamide Chemical compound CC1=CC=C(F)C=C1NC(=O)CN1CC(COC2(C)C)N2CC1 JMQGXDAAZNTETE-UHFFFAOYSA-N 0.000 description 2
- FJAZVXUPZQSZKI-UHFFFAOYSA-N 2-(4-fluorobenzoyl)benzoic acid Chemical compound OC(=O)C1=CC=CC=C1C(=O)C1=CC=C(F)C=C1 FJAZVXUPZQSZKI-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- OBAMOEWHGHFJFE-UHFFFAOYSA-N 2-chloro-n-(2,6-dichloro-4-cyanophenyl)acetamide Chemical compound ClCC(=O)NC1=C(Cl)C=C(C#N)C=C1Cl OBAMOEWHGHFJFE-UHFFFAOYSA-N 0.000 description 2
- FPQQSNUTBWFFLB-UHFFFAOYSA-N 2-chloro-n-(2,6-dimethylphenyl)acetamide Chemical compound CC1=CC=CC(C)=C1NC(=O)CCl FPQQSNUTBWFFLB-UHFFFAOYSA-N 0.000 description 2
- YQBGDNLIMVVOMR-UHFFFAOYSA-N 2-chloro-n-(5-fluoro-2-methylphenyl)acetamide Chemical compound CC1=CC=C(F)C=C1NC(=O)CCl YQBGDNLIMVVOMR-UHFFFAOYSA-N 0.000 description 2
- XQIRDUFEBBLNHM-UHFFFAOYSA-N 3-(4-fluorophenyl)-3-[3-(oxan-2-yloxy)propyl]-1h-2-benzofuran Chemical compound C1=CC(F)=CC=C1C1(CCCOC2OCCCC2)C2=CC=CC=C2CO1 XQIRDUFEBBLNHM-UHFFFAOYSA-N 0.000 description 2
- VQMPTVQCADWACQ-UHFFFAOYSA-N 3-methylpentan-3-amine Chemical compound CCC(C)(N)CC VQMPTVQCADWACQ-UHFFFAOYSA-N 0.000 description 2
- FZUIUPXKQDIJJW-UHFFFAOYSA-N 5-bromo-2,2-bis(4-fluorophenyl)pentanoyl chloride Chemical compound C1=CC(F)=CC=C1C(CCCBr)(C(Cl)=O)C1=CC=C(F)C=C1 FZUIUPXKQDIJJW-UHFFFAOYSA-N 0.000 description 2
- LTHQFSBKTYIXMG-UHFFFAOYSA-N 5-chloro-1,1-diphenylpentan-2-one Chemical compound C=1C=CC=CC=1C(C(=O)CCCCl)C1=CC=CC=C1 LTHQFSBKTYIXMG-UHFFFAOYSA-N 0.000 description 2
- OXBRQGQUNXSURU-UHFFFAOYSA-N 5-chloro-2,2-bis(4-fluorophenyl)pentanenitrile Chemical compound C1=CC(F)=CC=C1C(CCCCl)(C#N)C1=CC=C(F)C=C1 OXBRQGQUNXSURU-UHFFFAOYSA-N 0.000 description 2
- UPCCSTIFZGDVFN-UHFFFAOYSA-N 7-[4,4-bis(4-fluorophenyl)butyl]-3,3-dimethyl-5,6,8,8a-tetrahydro-1h-[1,3]oxazolo[3,4-a]pyrazine Chemical compound C1CN2C(C)(C)OCC2CN1CCCC(C=1C=CC(F)=CC=1)C1=CC=C(F)C=C1 UPCCSTIFZGDVFN-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- 229910015900 BF3 Inorganic materials 0.000 description 2
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 2
- 208000031229 Cardiomyopathies Diseases 0.000 description 2
- VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical compound ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 239000000908 ammonium hydroxide Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 2
- 235000013539 calcium stearate Nutrition 0.000 description 2
- 239000008116 calcium stearate Substances 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 2
- 150000004985 diamines Chemical class 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 210000003191 femoral vein Anatomy 0.000 description 2
- 239000007903 gelatin capsule Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000008240 homogeneous mixture Substances 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 239000003978 infusion fluid Substances 0.000 description 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- USOUQDOYCCSQBA-UHFFFAOYSA-N n-(2-hydroxyethyl)pyrazine-2-carboxamide Chemical compound OCCNC(=O)C1=CN=CC=N1 USOUQDOYCCSQBA-UHFFFAOYSA-N 0.000 description 2
- 229940100692 oral suspension Drugs 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 2
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- SIRSTRHGFGFVME-UHFFFAOYSA-N piperazin-2-ylmethanol Chemical compound OCC1CNCCN1 SIRSTRHGFGFVME-UHFFFAOYSA-N 0.000 description 2
- IVXQBCUBSIPQGU-UHFFFAOYSA-N piperazine-1-carboxamide Chemical compound NC(=O)N1CCNCC1 IVXQBCUBSIPQGU-UHFFFAOYSA-N 0.000 description 2
- RFIOZSIHFNEKFF-UHFFFAOYSA-M piperazine-1-carboxylate Chemical compound [O-]C(=O)N1CCNCC1 RFIOZSIHFNEKFF-UHFFFAOYSA-M 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000001294 propane Substances 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 230000010410 reperfusion Effects 0.000 description 2
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 238000010956 selective crystallization Methods 0.000 description 2
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 235000009518 sodium iodide Nutrition 0.000 description 2
- 239000012265 solid product Substances 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 238000007910 systemic administration Methods 0.000 description 2
- 229940066771 systemic antihistamines piperazine derivative Drugs 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 2
- ONKGVHYTGPECGC-CRCLSJGQSA-N (2r,3s)-3-methylpiperazine-2-carboxamide Chemical compound C[C@@H]1NCCN[C@H]1C(N)=O ONKGVHYTGPECGC-CRCLSJGQSA-N 0.000 description 1
- VIJSPAIQWVPKQZ-BLECARSGSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-4-methylpentanoyl]amino]-4,4-dimethylpentanoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(C)=O VIJSPAIQWVPKQZ-BLECARSGSA-N 0.000 description 1
- FNHHVPPSBFQMEL-KQHDFZBMSA-N (3S)-5-N-[(1S,5R)-3-hydroxy-6-bicyclo[3.1.0]hexanyl]-7-N,3-dimethyl-3-phenyl-2H-1-benzofuran-5,7-dicarboxamide Chemical compound CNC(=O)c1cc(cc2c1OC[C@@]2(C)c1ccccc1)C(=O)NC1[C@H]2CC(O)C[C@@H]12 FNHHVPPSBFQMEL-KQHDFZBMSA-N 0.000 description 1
- OOKAZRDERJMRCJ-KOUAFAAESA-N (3r)-7-[(1s,2s,4ar,6s,8s)-2,6-dimethyl-8-[(2s)-2-methylbutanoyl]oxy-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]-3-hydroxy-5-oxoheptanoic acid Chemical compound C1=C[C@H](C)[C@H](CCC(=O)C[C@@H](O)CC(O)=O)C2[C@@H](OC(=O)[C@@H](C)CC)C[C@@H](C)C[C@@H]21 OOKAZRDERJMRCJ-KOUAFAAESA-N 0.000 description 1
- MPDDTAJMJCESGV-CTUHWIOQSA-M (3r,5r)-7-[2-(4-fluorophenyl)-5-[methyl-[(1r)-1-phenylethyl]carbamoyl]-4-propan-2-ylpyrazol-3-yl]-3,5-dihydroxyheptanoate Chemical compound C1([C@@H](C)N(C)C(=O)C2=NN(C(CC[C@@H](O)C[C@@H](O)CC([O-])=O)=C2C(C)C)C=2C=CC(F)=CC=2)=CC=CC=C1 MPDDTAJMJCESGV-CTUHWIOQSA-M 0.000 description 1
- PJMFGDYBTJEEDP-UHFFFAOYSA-N (4-benzylpiperazin-2-yl)methanol Chemical compound C1CNC(CO)CN1CC1=CC=CC=C1 PJMFGDYBTJEEDP-UHFFFAOYSA-N 0.000 description 1
- ASEKJAWQXVPZTQ-UHFFFAOYSA-N (5-fluoro-2-hydroxyphenyl)-(4-fluorophenyl)methanone Chemical compound OC1=CC=C(F)C=C1C(=O)C1=CC=C(F)C=C1 ASEKJAWQXVPZTQ-UHFFFAOYSA-N 0.000 description 1
- IWYDHOAUDWTVEP-ZETCQYMHSA-N (S)-mandelic acid Chemical compound OC(=O)[C@@H](O)C1=CC=CC=C1 IWYDHOAUDWTVEP-ZETCQYMHSA-N 0.000 description 1
- DEVSOMFAQLZNKR-RJRFIUFISA-N (z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-n'-pyrazin-2-ylprop-2-enehydrazide Chemical compound FC(F)(F)C1=CC(C(F)(F)F)=CC(C2=NN(\C=C/C(=O)NNC=3N=CC=NC=3)C=N2)=C1 DEVSOMFAQLZNKR-RJRFIUFISA-N 0.000 description 1
- UOCLXMDMGBRAIB-UHFFFAOYSA-N 1,1,1-trichloroethane Chemical compound CC(Cl)(Cl)Cl UOCLXMDMGBRAIB-UHFFFAOYSA-N 0.000 description 1
- NEBUAXHKABBELF-UHFFFAOYSA-N 1,4-dibenzyl-2-(1-methoxyethyl)piperazine Chemical compound C1CN(CC=2C=CC=CC=2)C(C(C)OC)CN1CC1=CC=CC=C1 NEBUAXHKABBELF-UHFFFAOYSA-N 0.000 description 1
- ZCLFLEOFCABMMJ-UHFFFAOYSA-N 1,4-dibenzyl-2-(ethoxymethyl)piperazine Chemical compound C1CN(CC=2C=CC=CC=2)C(COCC)CN1CC1=CC=CC=C1 ZCLFLEOFCABMMJ-UHFFFAOYSA-N 0.000 description 1
- AEFZVMAENDWYTI-UHFFFAOYSA-N 1-(4-benzylpiperazin-2-yl)ethanol Chemical compound C1CNC(C(O)C)CN1CC1=CC=CC=C1 AEFZVMAENDWYTI-UHFFFAOYSA-N 0.000 description 1
- MZWDCIZZMVFGOU-UHFFFAOYSA-N 1-[2-(2,6-dimethylanilino)-2-oxoethyl]-n,n-dimethylpiperazine-2-carboxamide Chemical compound CN(C)C(=O)C1CNCCN1CC(=O)NC1=C(C)C=CC=C1C MZWDCIZZMVFGOU-UHFFFAOYSA-N 0.000 description 1
- BAWIAMQSTIGJFX-UHFFFAOYSA-N 1-[2-(2,6-dimethylanilino)-2-oxoethyl]piperazine-2-carboxamide Chemical compound CC1=CC=CC(C)=C1NC(=O)CN1C(C(N)=O)CNCC1 BAWIAMQSTIGJFX-UHFFFAOYSA-N 0.000 description 1
- FFEFFMLVFNFYPA-UHFFFAOYSA-N 1-[2-chloroethoxy-(4-fluorophenyl)methyl]-4-fluorobenzene Chemical compound C1=CC(F)=CC=C1C(OCCCl)C1=CC=C(F)C=C1 FFEFFMLVFNFYPA-UHFFFAOYSA-N 0.000 description 1
- GCGHJEQBUOSPOI-UHFFFAOYSA-N 1-[3,3-bis(4-fluorophenyl)propyl]-4-[2-(2,6-dimethylanilino)-2-oxoethyl]piperazine-2-carboxamide Chemical compound CC1=CC=CC(C)=C1NC(=O)CN1CC(C(N)=O)N(CCC(C=2C=CC(F)=CC=2)C=2C=CC(F)=CC=2)CC1 GCGHJEQBUOSPOI-UHFFFAOYSA-N 0.000 description 1
- CAEGSEJNBXUDOD-UHFFFAOYSA-N 1-[4,4-bis(4-fluorophenyl)butyl]-4-[2-(2,6-dichloroanilino)-2-oxoethyl]piperazine-2-carboxamide;hydrate;dihydrochloride Chemical compound O.Cl.Cl.C1CN(CCCC(C=2C=CC(F)=CC=2)C=2C=CC(F)=CC=2)C(C(=O)N)CN1CC(=O)NC1=C(Cl)C=CC=C1Cl CAEGSEJNBXUDOD-UHFFFAOYSA-N 0.000 description 1
- HLMVZQJVPGCERV-UHFFFAOYSA-N 1-[4,4-bis(4-fluorophenyl)butyl]-4-[2-(2,6-dichloroanilino)-2-oxoethyl]piperazine-2-carboxylic acid Chemical compound C1CN(CCCC(C=2C=CC(F)=CC=2)C=2C=CC(F)=CC=2)C(C(=O)O)CN1CC(=O)NC1=C(Cl)C=CC=C1Cl HLMVZQJVPGCERV-UHFFFAOYSA-N 0.000 description 1
- JMDZIZRKANMOFK-UHFFFAOYSA-N 1-[4,4-bis(4-fluorophenyl)butyl]-4-[2-(2,6-dimethylanilino)-2-oxoethyl]piperazine-2-carboxamide Chemical compound CC1=CC=CC(C)=C1NC(=O)CN1CC(C(N)=O)N(CCCC(C=2C=CC(F)=CC=2)C=2C=CC(F)=CC=2)CC1 JMDZIZRKANMOFK-UHFFFAOYSA-N 0.000 description 1
- XBBQFRJZTPITGT-BTJKTKAUSA-N 1-[4,4-bis(4-fluorophenyl)butyl]-4-[2-(2,6-dimethylanilino)-2-oxoethyl]piperazine-2-carboxamide;(z)-but-2-enedioic acid Chemical compound OC(=O)\C=C/C(O)=O.CC1=CC=CC(C)=C1NC(=O)CN1CC(C(N)=O)N(CCCC(C=2C=CC(F)=CC=2)C=2C=CC(F)=CC=2)CC1 XBBQFRJZTPITGT-BTJKTKAUSA-N 0.000 description 1
- ZWCWARJVSZSJCA-UHFFFAOYSA-N 1-[4,4-bis(4-fluorophenyl)butyl]-4-[2-(2,6-dimethylanilino)-2-oxoethyl]piperazine-2-carboxylic acid Chemical compound CC1=CC=CC(C)=C1NC(=O)CN1CC(C(O)=O)N(CCCC(C=2C=CC(F)=CC=2)C=2C=CC(F)=CC=2)CC1 ZWCWARJVSZSJCA-UHFFFAOYSA-N 0.000 description 1
- YXLDELQUTKPVNH-UHFFFAOYSA-N 1-[4,4-bis(4-fluorophenyl)butyl]-4-[3-(2,6-dimethylanilino)-3-oxopropyl]piperazine-2-carboxamide Chemical compound CC1=CC=CC(C)=C1NC(=O)CCN1CC(C(N)=O)N(CCCC(C=2C=CC(F)=CC=2)C=2C=CC(F)=CC=2)CC1 YXLDELQUTKPVNH-UHFFFAOYSA-N 0.000 description 1
- AOLZKLKQSZDIFE-UHFFFAOYSA-N 1-[4,4-bis(4-fluorophenyl)butyl]-n,n-dimethylpiperazine-2-carboxamide Chemical compound CN(C)C(=O)C1CNCCN1CCCC(C=1C=CC(F)=CC=1)C1=CC=C(F)C=C1 AOLZKLKQSZDIFE-UHFFFAOYSA-N 0.000 description 1
- NOFSNSNAIHZJSS-UHFFFAOYSA-N 1-[4,4-bis(4-fluorophenyl)pentyl]-4-[2-(2,6-dichloroanilino)-2-oxoethyl]piperazine-2-carboxamide;hydrate;dihydrochloride Chemical compound O.Cl.Cl.C=1C=C(F)C=CC=1C(C=1C=CC(F)=CC=1)(C)CCCN(C(C1)C(N)=O)CCN1CC(=O)NC1=C(Cl)C=CC=C1Cl NOFSNSNAIHZJSS-UHFFFAOYSA-N 0.000 description 1
- GVJIDMHQRWQFLD-UHFFFAOYSA-N 1-[4-[4,4-bis(4-fluorophenyl)butyl]-2-(methoxymethyl)piperazin-1-yl]-2,2,2-trifluoroethanone Chemical compound C1CN(C(=O)C(F)(F)F)C(COC)CN1CCCC(C=1C=CC(F)=CC=1)C1=CC=C(F)C=C1 GVJIDMHQRWQFLD-UHFFFAOYSA-N 0.000 description 1
- AIZKHKIKQBOULC-UHFFFAOYSA-N 1-[5-chloro-1-(4-fluorophenyl)pentyl]-4-fluorobenzene Chemical compound C1=CC(F)=CC=C1C(CCCCCl)C1=CC=C(F)C=C1 AIZKHKIKQBOULC-UHFFFAOYSA-N 0.000 description 1
- GLCRMWHGJAUWFV-UHFFFAOYSA-N 1-benzyl-3-(ethoxymethyl)piperazine Chemical compound C1CNC(COCC)CN1CC1=CC=CC=C1 GLCRMWHGJAUWFV-UHFFFAOYSA-N 0.000 description 1
- YIEFLWXFDITFQT-UHFFFAOYSA-N 1-cyclopropyl-2,2-diphenylethanone Chemical compound C1CC1C(=O)C(C=1C=CC=CC=1)C1=CC=CC=C1 YIEFLWXFDITFQT-UHFFFAOYSA-N 0.000 description 1
- VCMQRVDQQAMQTJ-UHFFFAOYSA-N 2,2,2-trifluoro-1-piperazin-1-ylethanone Chemical compound FC(F)(F)C(=O)N1CCNCC1 VCMQRVDQQAMQTJ-UHFFFAOYSA-N 0.000 description 1
- BGUDVVGWDPOKAY-UHFFFAOYSA-N 2,3-dibromobutanamide Chemical compound CC(Br)C(Br)C(N)=O BGUDVVGWDPOKAY-UHFFFAOYSA-N 0.000 description 1
- KTSYJOCXLHRTTJ-UHFFFAOYSA-N 2-(1-methoxyethyl)piperazine Chemical compound COC(C)C1CNCCN1 KTSYJOCXLHRTTJ-UHFFFAOYSA-N 0.000 description 1
- ZIHFEIOZBJJBJZ-UHFFFAOYSA-N 2-(2-hydroxyethyl)-3,3-dimethyl-6,7,8,8a-tetrahydro-5h-imidazo[1,5-a]pyrazin-1-one Chemical compound C1CNCC2C(=O)N(CCO)C(C)(C)N21 ZIHFEIOZBJJBJZ-UHFFFAOYSA-N 0.000 description 1
- HPHPLBHZLAJOGQ-UHFFFAOYSA-N 2-(3,3-dimethyl-1-oxo-2-propan-2-yl-5,6,8,8a-tetrahydroimidazo[1,5-a]pyrazin-7-yl)-n-(2,6-dimethylphenyl)acetamide Chemical compound C1CN2C(C)(C)N(C(C)C)C(=O)C2CN1CC(=O)NC1=C(C)C=CC=C1C HPHPLBHZLAJOGQ-UHFFFAOYSA-N 0.000 description 1
- PXYOVCSGVWVUIT-UHFFFAOYSA-N 2-(3,3-dimethyl-5,6,8,8a-tetrahydro-1h-[1,3]oxazolo[3,4-a]pyrazin-7-yl)-n-(2,6-dimethyl-4-nitrophenyl)acetamide Chemical compound CC1=CC([N+]([O-])=O)=CC(C)=C1NC(=O)CN1CC(COC2(C)C)N2CC1 PXYOVCSGVWVUIT-UHFFFAOYSA-N 0.000 description 1
- HJNHUFQGDJLQRS-UHFFFAOYSA-N 2-(3-bromopropoxy)oxane Chemical compound BrCCCOC1CCCCO1 HJNHUFQGDJLQRS-UHFFFAOYSA-N 0.000 description 1
- JHQBLYITVCBGTO-UHFFFAOYSA-N 2-(4-fluorophenyl)acetonitrile Chemical compound FC1=CC=C(CC#N)C=C1 JHQBLYITVCBGTO-UHFFFAOYSA-N 0.000 description 1
- SGYRPTNVBJHMGM-UHFFFAOYSA-N 2-(ethoxymethyl)piperazine Chemical compound CCOCC1CNCCN1 SGYRPTNVBJHMGM-UHFFFAOYSA-N 0.000 description 1
- VSKJXHRGVSZNRH-UHFFFAOYSA-N 2-(methoxymethyl)piperazine Chemical compound COCC1CNCCN1 VSKJXHRGVSZNRH-UHFFFAOYSA-N 0.000 description 1
- BKYSFVJCBRHGMA-UHFFFAOYSA-N 2-(naphthalen-2-yloxymethyl)oxirane Chemical compound C=1C=C2C=CC=CC2=CC=1OCC1CO1 BKYSFVJCBRHGMA-UHFFFAOYSA-N 0.000 description 1
- VBLXCTYLWZJBKA-UHFFFAOYSA-N 2-(trifluoromethyl)aniline Chemical compound NC1=CC=CC=C1C(F)(F)F VBLXCTYLWZJBKA-UHFFFAOYSA-N 0.000 description 1
- NTEDSJJNSHCSIR-UHFFFAOYSA-N 2-[1-[2-(2,6-dimethylanilino)-2-oxoethyl]piperazin-2-yl]acetamide Chemical compound CC1=CC=CC(C)=C1NC(=O)CN1C(CC(N)=O)CNCC1 NTEDSJJNSHCSIR-UHFFFAOYSA-N 0.000 description 1
- ZBIAKUMOEKILTF-UHFFFAOYSA-N 2-[4-[4,4-bis(4-fluorophenyl)butyl]-1-piperazinyl]-N-(2,6-dimethylphenyl)acetamide Chemical compound CC1=CC=CC(C)=C1NC(=O)CN1CCN(CCCC(C=2C=CC(F)=CC=2)C=2C=CC(F)=CC=2)CC1 ZBIAKUMOEKILTF-UHFFFAOYSA-N 0.000 description 1
- JFTKQYCHZKVSFR-UHFFFAOYSA-N 2-[4-[4,4-bis(4-fluorophenyl)butyl]-2-(hydroxymethyl)piperazin-1-yl]-n-(2,6-dimethyl-4-nitrophenyl)acetamide Chemical compound CC1=CC([N+]([O-])=O)=CC(C)=C1NC(=O)CN1C(CO)CN(CCCC(C=2C=CC(F)=CC=2)C=2C=CC(F)=CC=2)CC1 JFTKQYCHZKVSFR-UHFFFAOYSA-N 0.000 description 1
- GUSNJJUYRLNNBA-UHFFFAOYSA-N 2-[4-[4,4-bis(4-fluorophenyl)butyl]-3-(hydroxymethyl)piperazin-1-yl]-n-(2-chloro-6-methylphenyl)acetamide Chemical compound CC1=CC=CC(Cl)=C1NC(=O)CN1CC(CO)N(CCCC(C=2C=CC(F)=CC=2)C=2C=CC(F)=CC=2)CC1 GUSNJJUYRLNNBA-UHFFFAOYSA-N 0.000 description 1
- CZAFLRAOEDDMCS-UHFFFAOYSA-N 2-chloro-n-(2,6-dichlorophenyl)acetamide Chemical compound ClCC(=O)NC1=C(Cl)C=CC=C1Cl CZAFLRAOEDDMCS-UHFFFAOYSA-N 0.000 description 1
- SWSWELOJKQQJGV-UHFFFAOYSA-N 2-chloro-n-(2-methyl-4-nitrophenyl)acetamide Chemical compound CC1=CC([N+]([O-])=O)=CC=C1NC(=O)CCl SWSWELOJKQQJGV-UHFFFAOYSA-N 0.000 description 1
- VBZYFFFDWPGZDG-UHFFFAOYSA-N 2-chloro-n-(5-chloro-2-methoxy-4-nitrophenyl)acetamide Chemical compound COC1=CC([N+]([O-])=O)=C(Cl)C=C1NC(=O)CCl VBZYFFFDWPGZDG-UHFFFAOYSA-N 0.000 description 1
- WAGYENKYIROKOE-UHFFFAOYSA-N 2-chloro-n-(5-chloro-2-methylphenyl)acetamide Chemical compound CC1=CC=C(Cl)C=C1NC(=O)CCl WAGYENKYIROKOE-UHFFFAOYSA-N 0.000 description 1
- CUKHIOWSHUAINH-UHFFFAOYSA-N 2-chloro-n-[2-methoxy-5-(trifluoromethyl)phenyl]acetamide Chemical compound COC1=CC=C(C(F)(F)F)C=C1NC(=O)CCl CUKHIOWSHUAINH-UHFFFAOYSA-N 0.000 description 1
- SZIFAVKTNFCBPC-UHFFFAOYSA-N 2-chloroethanol Chemical compound OCCCl SZIFAVKTNFCBPC-UHFFFAOYSA-N 0.000 description 1
- YSRSFSHRXSKXNN-UHFFFAOYSA-N 2-fluoro-n-(4-fluorophenyl)benzamide Chemical compound C1=CC(F)=CC=C1NC(=O)C1=CC=CC=C1F YSRSFSHRXSKXNN-UHFFFAOYSA-N 0.000 description 1
- LODHFNUFVRVKTH-ZHACJKMWSA-N 2-hydroxy-n'-[(e)-3-phenylprop-2-enoyl]benzohydrazide Chemical compound OC1=CC=CC=C1C(=O)NNC(=O)\C=C\C1=CC=CC=C1 LODHFNUFVRVKTH-ZHACJKMWSA-N 0.000 description 1
- NMPGHGKEQNHEMI-UHFFFAOYSA-N 2-piperazin-2-ylacetamide Chemical compound NC(=O)CC1CNCCN1 NMPGHGKEQNHEMI-UHFFFAOYSA-N 0.000 description 1
- YBCDAJXDNHLDFS-UHFFFAOYSA-N 3,3-bis(4-fluorophenyl)oxan-2-one Chemical compound C1=CC(F)=CC=C1C1(C=2C=CC(F)=CC=2)C(=O)OCCC1 YBCDAJXDNHLDFS-UHFFFAOYSA-N 0.000 description 1
- DOZMYMGJEIXXKZ-UHFFFAOYSA-N 3,3-dimethyl-1,5,6,7,8,8a-hexahydro-[1,3]oxazolo[3,4-a]pyrazine Chemical compound C1NCCN2C(C)(C)OCC21 DOZMYMGJEIXXKZ-UHFFFAOYSA-N 0.000 description 1
- IEYKCXJYWXSHCR-UHFFFAOYSA-N 3,3-dimethyl-2,5,6,7,8,8a-hexahydroimidazo[1,5-a]pyrazin-1-one Chemical compound C1NCCN2C(C)(C)NC(=O)C21 IEYKCXJYWXSHCR-UHFFFAOYSA-N 0.000 description 1
- UTFSZXYZDHQKEI-UHFFFAOYSA-N 3,3-dimethyl-2-propan-2-yl-6,7,8,8a-tetrahydro-5h-imidazo[1,5-a]pyrazin-1-one Chemical compound C1NCCN2C(C)(C)N(C(C)C)C(=O)C21 UTFSZXYZDHQKEI-UHFFFAOYSA-N 0.000 description 1
- LIUKFSSXTLPHLN-UHFFFAOYSA-N 3-(3-chloropropyl)-3-(4-fluorophenyl)-1h-2-benzofuran Chemical compound C1=CC(F)=CC=C1C1(CCCCl)C2=CC=CC=C2CO1 LIUKFSSXTLPHLN-UHFFFAOYSA-N 0.000 description 1
- NHAUFRDVNSOWTA-UHFFFAOYSA-N 3-[1-(4-fluorophenyl)-3h-2-benzofuran-1-yl]propan-1-ol Chemical compound O1CC2=CC=CC=C2C1(CCCO)C1=CC=C(F)C=C1 NHAUFRDVNSOWTA-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- CDOUZKKFHVEKRI-UHFFFAOYSA-N 3-bromo-n-[(prop-2-enoylamino)methyl]propanamide Chemical compound BrCCC(=O)NCNC(=O)C=C CDOUZKKFHVEKRI-UHFFFAOYSA-N 0.000 description 1
- NEVQMNGGZJHABG-UHFFFAOYSA-N 3-chloro-n-(2,6-dichlorophenyl)propanamide Chemical compound ClCCC(=O)NC1=C(Cl)C=CC=C1Cl NEVQMNGGZJHABG-UHFFFAOYSA-N 0.000 description 1
- VOTVVKNPQNCBKS-UHFFFAOYSA-N 3-chloro-n-(2,6-dimethylphenyl)propanamide Chemical compound CC1=CC=CC(C)=C1NC(=O)CCCl VOTVVKNPQNCBKS-UHFFFAOYSA-N 0.000 description 1
- SSZWWUDQMAHNAQ-UHFFFAOYSA-N 3-chloropropane-1,2-diol Chemical compound OCC(O)CCl SSZWWUDQMAHNAQ-UHFFFAOYSA-N 0.000 description 1
- USTQGAMERBAVRC-UHFFFAOYSA-N 3h-[1,3]oxazolo[3,4-a]pyrazine Chemical compound C1=NC=CN2COC=C21 USTQGAMERBAVRC-UHFFFAOYSA-N 0.000 description 1
- JTZRUHGVAQOPSE-UHFFFAOYSA-N 4,4-bis(4-fluorophenyl)cyclohexan-1-one Chemical compound C1=CC(F)=CC=C1C1(C=2C=CC(F)=CC=2)CCC(=O)CC1 JTZRUHGVAQOPSE-UHFFFAOYSA-N 0.000 description 1
- NDUUQGTVQYNKIY-UHFFFAOYSA-N 4-(3-phenylprop-2-enyl)piperazine-2-carboxamide Chemical compound C1CNC(C(=O)N)CN1CC=CC1=CC=CC=C1 NDUUQGTVQYNKIY-UHFFFAOYSA-N 0.000 description 1
- JFJXHTCDSDMHPT-UHFFFAOYSA-N 4-(4-fluorophenyl)-4-hydroxycyclohexan-1-one Chemical compound C=1C=C(F)C=CC=1C1(O)CCC(=O)CC1 JFJXHTCDSDMHPT-UHFFFAOYSA-N 0.000 description 1
- DMYMMJJUFRJLNS-UHFFFAOYSA-N 4-(chloromethyl)-2,2-bis(4-fluorophenyl)-1,3-dioxolane Chemical compound C1=CC(F)=CC=C1C1(C=2C=CC(F)=CC=2)OC(CCl)CO1 DMYMMJJUFRJLNS-UHFFFAOYSA-N 0.000 description 1
- AJQXOKUHERCLKW-UHFFFAOYSA-N 4-[2-(2,6-dichloroanilino)-2-oxoethyl]-1-(2-hydroxy-3-naphthalen-2-yloxypropyl)piperazine-2-carboxamide;hydrate;dihydrochloride Chemical compound O.Cl.Cl.C1CN(CC(O)COC=2C=C3C=CC=CC3=CC=2)C(C(=O)N)CN1CC(=O)NC1=C(Cl)C=CC=C1Cl AJQXOKUHERCLKW-UHFFFAOYSA-N 0.000 description 1
- MHLJEWPCJZYGOE-UHFFFAOYSA-N 4-[2-(2,6-dichloroanilino)-2-oxoethyl]piperazine-2-carboxamide Chemical compound C1CNC(C(=O)N)CN1CC(=O)NC1=C(Cl)C=CC=C1Cl MHLJEWPCJZYGOE-UHFFFAOYSA-N 0.000 description 1
- PJZRLSGZQRBTFY-UHFFFAOYSA-N 4-[2-(4-amino-2,6-dimethylanilino)-2-oxoethyl]-1-[4,4-bis(4-fluorophenyl)butyl]piperazine-2-carboxamide Chemical compound CC1=CC(N)=CC(C)=C1NC(=O)CN1CC(C(N)=O)N(CCCC(C=2C=CC(F)=CC=2)C=2C=CC(F)=CC=2)CC1 PJZRLSGZQRBTFY-UHFFFAOYSA-N 0.000 description 1
- DDMSAQXPSBWHCC-UHFFFAOYSA-N 4-[2-(4-amino-2-methylanilino)-2-oxoethyl]-1-[4,4-bis(4-fluorophenyl)butyl]-n-methylpiperazine-2-carboxamide Chemical compound C1CN(CCCC(C=2C=CC(F)=CC=2)C=2C=CC(F)=CC=2)C(C(=O)NC)CN1CC(=O)NC1=CC=C(N)C=C1C DDMSAQXPSBWHCC-UHFFFAOYSA-N 0.000 description 1
- OZUGOVQLKNFQJZ-UHFFFAOYSA-N 4-[2-(4-aminoanilino)-2-oxoethyl]-1-[4,4-bis(4-fluorophenyl)butyl]piperazine-2-carboxamide;hydrate Chemical compound O.C1CN(CCCC(C=2C=CC(F)=CC=2)C=2C=CC(F)=CC=2)C(C(=O)N)CN1CC(=O)NC1=CC=C(N)C=C1 OZUGOVQLKNFQJZ-UHFFFAOYSA-N 0.000 description 1
- NXGJKONAYDAYPF-UHFFFAOYSA-N 4-[4,4-bis(4-fluorophenyl)butyl]-1-[2-(2,6-dimethyl-4-nitroanilino)-2-oxoethyl]-n-methylpiperazine-2-carboxamide Chemical compound C1CN(CC(=O)NC=2C(=CC(=CC=2C)[N+]([O-])=O)C)C(C(=O)NC)CN1CCCC(C=1C=CC(F)=CC=1)C1=CC=C(F)C=C1 NXGJKONAYDAYPF-UHFFFAOYSA-N 0.000 description 1
- DJISHVDSPXXKQK-UHFFFAOYSA-N 4-[4,4-bis(4-fluorophenyl)butyl]-n-methylpiperazine-2-carboxamide Chemical compound C1CNC(C(=O)NC)CN1CCCC(C=1C=CC(F)=CC=1)C1=CC=C(F)C=C1 DJISHVDSPXXKQK-UHFFFAOYSA-N 0.000 description 1
- ZOQMOZXKIYOPHM-UHFFFAOYSA-N 4-[4,4-bis(4-fluorophenyl)butyl]piperazine-2-carboxamide Chemical compound C1CNC(C(=O)N)CN1CCCC(C=1C=CC(F)=CC=1)C1=CC=C(F)C=C1 ZOQMOZXKIYOPHM-UHFFFAOYSA-N 0.000 description 1
- WRIPWWNUAVPVJR-UHFFFAOYSA-N 4-benzyl-1-[4,4-bis(4-fluorophenyl)butyl]-n,n-dimethylpiperazine-2-carboxamide Chemical compound C1CN(CCCC(C=2C=CC(F)=CC=2)C=2C=CC(F)=CC=2)C(C(=O)N(C)C)CN1CC1=CC=CC=C1 WRIPWWNUAVPVJR-UHFFFAOYSA-N 0.000 description 1
- ZZRHUTDXMFRDHF-UHFFFAOYSA-N 4-benzyl-1-[4,4-bis(4-fluorophenyl)butyl]piperazine-2-carboxamide Chemical compound C1CN(CCCC(C=2C=CC(F)=CC=2)C=2C=CC(F)=CC=2)C(C(=O)N)CN1CC1=CC=CC=C1 ZZRHUTDXMFRDHF-UHFFFAOYSA-N 0.000 description 1
- GZUGYWRPVVWSTA-UHFFFAOYSA-N 4-benzyl-n,n-dimethylpiperazine-2-carboxamide Chemical compound C1CNC(C(=O)N(C)C)CN1CC1=CC=CC=C1 GZUGYWRPVVWSTA-UHFFFAOYSA-N 0.000 description 1
- WGIWJDQRXFTODM-UHFFFAOYSA-N 4-benzylpiperazine-2-carboxamide Chemical compound C1CNC(C(=O)N)CN1CC1=CC=CC=C1 WGIWJDQRXFTODM-UHFFFAOYSA-N 0.000 description 1
- WRFYIYOXJWKONR-UHFFFAOYSA-N 4-bromo-2-methoxyaniline Chemical compound COC1=CC(Br)=CC=C1N WRFYIYOXJWKONR-UHFFFAOYSA-N 0.000 description 1
- SDQOPRDHXLLYOF-UHFFFAOYSA-N 4-fluoro-n-(4-fluorophenyl)benzamide Chemical compound C1=CC(F)=CC=C1NC(=O)C1=CC=C(F)C=C1 SDQOPRDHXLLYOF-UHFFFAOYSA-N 0.000 description 1
- OWEBETPMTQJABO-UHFFFAOYSA-N 5-bromo-2,2-bis(4-fluorophenyl)pentanoic acid Chemical compound C=1C=C(F)C=CC=1C(CCCBr)(C(=O)O)C1=CC=C(F)C=C1 OWEBETPMTQJABO-UHFFFAOYSA-N 0.000 description 1
- OZJPLYNZGCXSJM-UHFFFAOYSA-N 5-valerolactone Chemical compound O=C1CCCCO1 OZJPLYNZGCXSJM-UHFFFAOYSA-N 0.000 description 1
- MORDVMYMQZFSTL-UHFFFAOYSA-N 7-[4,4-bis(4-fluorophenyl)butyl]-2,3,3-trimethyl-5,6,8,8a-tetrahydroimidazo[1,5-a]pyrazin-1-one hydrochloride Chemical compound Cl.C1CN2C(C)(C)N(C)C(=O)C2CN1CCCC(C=1C=CC(F)=CC=1)C1=CC=C(F)C=C1 MORDVMYMQZFSTL-UHFFFAOYSA-N 0.000 description 1
- OFHKGJDLWDCBIN-UHFFFAOYSA-N 7-[4,4-bis(4-fluorophenyl)butyl]-2-(2-hydroxyethyl)-3,3-dimethyl-5,6,8,8a-tetrahydroimidazo[1,5-a]pyrazin-1-one Chemical compound C1C2C(=O)N(CCO)C(C)(C)N2CCN1CCCC(C=1C=CC(F)=CC=1)C1=CC=C(F)C=C1 OFHKGJDLWDCBIN-UHFFFAOYSA-N 0.000 description 1
- MYZAHJDBWCHLDU-UHFFFAOYSA-N 7-[4,4-bis(4-fluorophenyl)butyl]-3,3-dimethyl-2-propan-2-yl-5,6,8,8a-tetrahydroimidazo[1,5-a]pyrazin-1-one Chemical compound C1CN2C(C)(C)N(C(C)C)C(=O)C2CN1CCCC(C=1C=CC(F)=CC=1)C1=CC=C(F)C=C1 MYZAHJDBWCHLDU-UHFFFAOYSA-N 0.000 description 1
- IRBAWVGZNJIROV-SFHVURJKSA-N 9-(2-cyclopropylethynyl)-2-[[(2s)-1,4-dioxan-2-yl]methoxy]-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C1=C2C3=CC=C(C#CC4CC4)C=C3CCN2C(=O)N=C1OC[C@@H]1COCCO1 IRBAWVGZNJIROV-SFHVURJKSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical class [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- PKMUHQIDVVOXHQ-HXUWFJFHSA-N C[C@H](C1=CC(C2=CC=C(CNC3CCCC3)S2)=CC=C1)NC(C1=C(C)C=CC(NC2CNC2)=C1)=O Chemical compound C[C@H](C1=CC(C2=CC=C(CNC3CCCC3)S2)=CC=C1)NC(C1=C(C)C=CC(NC2CNC2)=C1)=O PKMUHQIDVVOXHQ-HXUWFJFHSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 229910021591 Copper(I) chloride Inorganic materials 0.000 description 1
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 208000021908 Myocardial disease Diseases 0.000 description 1
- LKJPYSCBVHEWIU-UHFFFAOYSA-N N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide Chemical compound C=1C=C(C#N)C(C(F)(F)F)=CC=1NC(=O)C(O)(C)CS(=O)(=O)C1=CC=C(F)C=C1 LKJPYSCBVHEWIU-UHFFFAOYSA-N 0.000 description 1
- ZSBDPRIWBYHIAF-UHFFFAOYSA-N N-acetyl-acetamide Natural products CC(=O)NC(C)=O ZSBDPRIWBYHIAF-UHFFFAOYSA-N 0.000 description 1
- NSXARWNAAHDHFZ-UHFFFAOYSA-N O.O.Cl.Cl.C1CN(CCCC(C=2C=CC(F)=CC=2)C=2C=CC(F)=CC=2)C(C(=O)N)CN1CC(=O)NC1=C(Cl)C=C(N)C=C1Cl Chemical compound O.O.Cl.Cl.C1CN(CCCC(C=2C=CC(F)=CC=2)C=2C=CC(F)=CC=2)C(C(=O)N)CN1CC(=O)NC1=C(Cl)C=C(N)C=C1Cl NSXARWNAAHDHFZ-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-N Salicylic acid Natural products OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- SPXSEZMVRJLHQG-XMMPIXPASA-N [(2R)-1-[[4-[(3-phenylmethoxyphenoxy)methyl]phenyl]methyl]pyrrolidin-2-yl]methanol Chemical compound C(C1=CC=CC=C1)OC=1C=C(OCC2=CC=C(CN3[C@H](CCC3)CO)C=C2)C=CC=1 SPXSEZMVRJLHQG-XMMPIXPASA-N 0.000 description 1
- UBTGAVSKFXPKBH-UHFFFAOYSA-N [2-(3-chloropropoxy)-5-fluorophenyl]-(4-fluorophenyl)methanone Chemical compound C1=CC(F)=CC=C1C(=O)C1=CC(F)=CC=C1OCCCCl UBTGAVSKFXPKBH-UHFFFAOYSA-N 0.000 description 1
- ZEUGGCMFIKNZNX-UHFFFAOYSA-N [4-[4,4-bis(4-fluorophenyl)butyl]piperazin-2-yl]methanol Chemical compound C1CNC(CO)CN1CCCC(C=1C=CC(F)=CC=1)C1=CC=C(F)C=C1 ZEUGGCMFIKNZNX-UHFFFAOYSA-N 0.000 description 1
- POMBFNAHCZQQLP-UHFFFAOYSA-N [C].N1CCNCC1 Chemical group [C].N1CCNCC1 POMBFNAHCZQQLP-UHFFFAOYSA-N 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910001516 alkali metal iodide Inorganic materials 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 229910001619 alkaline earth metal iodide Inorganic materials 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000002269 analeptic agent Substances 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 229940124339 anthelmintic agent Drugs 0.000 description 1
- 239000000921 anthelmintic agent Substances 0.000 description 1
- 239000004004 anti-anginal agent Substances 0.000 description 1
- 230000001601 anti-carrageenan Effects 0.000 description 1
- 229940124345 antianginal agent Drugs 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 150000001555 benzenes Chemical class 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- GNDHXHLGYBJDRD-UHFFFAOYSA-N bis(2-fluorophenyl)methanone Chemical compound FC1=CC=CC=C1C(=O)C1=CC=CC=C1F GNDHXHLGYBJDRD-UHFFFAOYSA-N 0.000 description 1
- WRKGTUUHIURRMW-UHFFFAOYSA-N bis(4-fluorophenyl)methanamine Chemical compound C=1C=C(F)C=CC=1C(N)C1=CC=C(F)C=C1 WRKGTUUHIURRMW-UHFFFAOYSA-N 0.000 description 1
- WCTZPQWLFWZYJE-UHFFFAOYSA-N bis(4-fluorophenyl)methanol Chemical compound C=1C=C(F)C=CC=1C(O)C1=CC=C(F)C=C1 WCTZPQWLFWZYJE-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- GZUXJHMPEANEGY-UHFFFAOYSA-N bromomethane Chemical compound BrC GZUXJHMPEANEGY-UHFFFAOYSA-N 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- XAAHAAMILDNBPS-UHFFFAOYSA-L calcium hydrogenphosphate dihydrate Chemical compound O.O.[Ca+2].OP([O-])([O-])=O XAAHAAMILDNBPS-UHFFFAOYSA-L 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 125000001951 carbamoylamino group Chemical group C(N)(=O)N* 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000001733 carboxylic acid esters Chemical group 0.000 description 1
- 238000010531 catalytic reduction reaction Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229940117975 chromium trioxide Drugs 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N chromium trioxide Inorganic materials O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- GAMDZJFZMJECOS-UHFFFAOYSA-N chromium(6+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[Cr+6] GAMDZJFZMJECOS-UHFFFAOYSA-N 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 229940127271 compound 49 Drugs 0.000 description 1
- 229940126179 compound 72 Drugs 0.000 description 1
- 239000007891 compressed tablet Substances 0.000 description 1
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 1
- 239000003218 coronary vasodilator agent Substances 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 229940045803 cuprous chloride Drugs 0.000 description 1
- 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 238000005661 deetherification reaction Methods 0.000 description 1
- YPUGLZQRXQQCSX-UHFFFAOYSA-N dibenzylpiperazine Chemical compound C=1C=CC=CC=1CN(CC1)CCN1CC1=CC=CC=C1 YPUGLZQRXQQCSX-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- 235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 description 1
- POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- UAVKNBIJLMRGJQ-UHFFFAOYSA-N ethyl 1-[4,4-bis(4-fluorophenyl)butyl]piperazine-2-carboxylate Chemical compound CCOC(=O)C1CNCCN1CCCC(C=1C=CC(F)=CC=1)C1=CC=C(F)C=C1 UAVKNBIJLMRGJQ-UHFFFAOYSA-N 0.000 description 1
- HCPOCMMGKBZWSJ-UHFFFAOYSA-N ethyl 3-hydrazinyl-3-oxopropanoate Chemical compound CCOC(=O)CC(=O)NN HCPOCMMGKBZWSJ-UHFFFAOYSA-N 0.000 description 1
- NFRMAYKGILJRDY-UHFFFAOYSA-N ethyl 4-benzhydrylpiperazine-2-carboxylate Chemical compound C1CNC(C(=O)OCC)CN1C(C=1C=CC=CC=1)C1=CC=CC=C1 NFRMAYKGILJRDY-UHFFFAOYSA-N 0.000 description 1
- PJSSQPCALQHBRC-UHFFFAOYSA-N ethyl 4-benzyl-1-[4,4-bis(4-fluorophenyl)butyl]piperazine-2-carboxylate Chemical compound C1CN(CCCC(C=2C=CC(F)=CC=2)C=2C=CC(F)=CC=2)C(C(=O)OCC)CN1CC1=CC=CC=C1 PJSSQPCALQHBRC-UHFFFAOYSA-N 0.000 description 1
- UWNOIXYBDFFGTL-UHFFFAOYSA-N ethyl 4-benzylpiperazine-2-carboxylate Chemical compound C1CNC(C(=O)OCC)CN1CC1=CC=CC=C1 UWNOIXYBDFFGTL-UHFFFAOYSA-N 0.000 description 1
- WSNXUEATCIQBEX-UHFFFAOYSA-N ethyl 5-bromo-2,2-bis(4-fluorophenyl)pentanoate Chemical compound C=1C=C(F)C=CC=1C(CCCBr)(C(=O)OCC)C1=CC=C(F)C=C1 WSNXUEATCIQBEX-UHFFFAOYSA-N 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- JKXCZYCVHPKTPK-UHFFFAOYSA-N hydrate;trihydrochloride Chemical compound O.Cl.Cl.Cl JKXCZYCVHPKTPK-UHFFFAOYSA-N 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- MIFJMFOVENWQDP-UHFFFAOYSA-N imidazo[1,5-a]pyrazine Chemical compound C1=CN=CC2=CN=CN21 MIFJMFOVENWQDP-UHFFFAOYSA-N 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- UEXQBEVWFZKHNB-UHFFFAOYSA-N intermediate 29 Natural products C1=CC(N)=CC=C1NC1=NC=CC=N1 UEXQBEVWFZKHNB-UHFFFAOYSA-N 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- FBAFATDZDUQKNH-UHFFFAOYSA-M iron chloride Chemical compound [Cl-].[Fe] FBAFATDZDUQKNH-UHFFFAOYSA-M 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000005240 left ventricle Anatomy 0.000 description 1
- 229960001941 lidoflazine Drugs 0.000 description 1
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 229960005015 local anesthetics Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- TWIIRMSFZNYMQE-UHFFFAOYSA-N methyl pyrazine-2-carboxylate Chemical compound COC(=O)C1=CN=CC=N1 TWIIRMSFZNYMQE-UHFFFAOYSA-N 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- AJFDBNQQDYLMJN-UHFFFAOYSA-N n,n-diethylacetamide Chemical compound CCN(CC)C(C)=O AJFDBNQQDYLMJN-UHFFFAOYSA-N 0.000 description 1
- NTEHWJBQADMGCG-UHFFFAOYSA-N n,n-dimethylformamide;nitrobenzene Chemical compound CN(C)C=O.[O-][N+](=O)C1=CC=CC=C1 NTEHWJBQADMGCG-UHFFFAOYSA-N 0.000 description 1
- MVWYSRAIAUAMJL-UHFFFAOYSA-N n,n-dimethylpiperazine-2-carboxamide Chemical compound CN(C)C(=O)C1CNCCN1 MVWYSRAIAUAMJL-UHFFFAOYSA-N 0.000 description 1
- CXAHNNQZUPGRAO-UHFFFAOYSA-N n-(2,6-dichlorophenyl)-2-(3,3-dimethyl-1-oxo-5,6,8,8a-tetrahydro-2h-imidazo[1,5-a]pyrazin-7-yl)acetamide Chemical compound C1CN2C(C)(C)NC(=O)C2CN1CC(=O)NC1=C(Cl)C=CC=C1Cl CXAHNNQZUPGRAO-UHFFFAOYSA-N 0.000 description 1
- PTJCVDMNAWRSIT-UHFFFAOYSA-N n-(2,6-dichlorophenyl)-2-(3,3-dimethyl-5,6,8,8a-tetrahydro-1h-[1,3]oxazolo[3,4-a]pyrazin-7-yl)acetamide Chemical compound C1CN2C(C)(C)OCC2CN1CC(=O)NC1=C(Cl)C=CC=C1Cl PTJCVDMNAWRSIT-UHFFFAOYSA-N 0.000 description 1
- HHLMJQSMYXVMKM-UHFFFAOYSA-N n-(2,6-dimethyl-4-nitrophenyl)-2-[3-(hydroxymethyl)piperazin-1-yl]acetamide Chemical compound CC1=CC([N+]([O-])=O)=CC(C)=C1NC(=O)CN1CC(CO)NCC1 HHLMJQSMYXVMKM-UHFFFAOYSA-N 0.000 description 1
- UNGPZBQLRHISBN-UHFFFAOYSA-N n-(2,6-dimethylphenyl)-2-[2-(ethoxymethyl)piperazin-1-yl]acetamide Chemical compound CCOCC1CNCCN1CC(=O)NC1=C(C)C=CC=C1C UNGPZBQLRHISBN-UHFFFAOYSA-N 0.000 description 1
- HXDCVEUSOMDNHE-UHFFFAOYSA-N n-(2,6-dimethylphenyl)-2-[2-(hydroxymethyl)piperazin-1-yl]acetamide Chemical compound CC1=CC=CC(C)=C1NC(=O)CN1C(CO)CNCC1 HXDCVEUSOMDNHE-UHFFFAOYSA-N 0.000 description 1
- NKYNCONCBQBUCX-UHFFFAOYSA-N n-(2,6-dimethylphenyl)-2-[2-(methoxymethyl)piperazin-1-yl]acetamide Chemical compound COCC1CNCCN1CC(=O)NC1=C(C)C=CC=C1C NKYNCONCBQBUCX-UHFFFAOYSA-N 0.000 description 1
- FMYOZCVZHXQCMK-UHFFFAOYSA-N n-(2-chloro-6-methylphenyl)-2-(3,3-dimethyl-5,6,8,8a-tetrahydro-1h-[1,3]oxazolo[3,4-a]pyrazin-7-yl)acetamide Chemical compound CC1=CC=CC(Cl)=C1NC(=O)CN1CC(COC2(C)C)N2CC1 FMYOZCVZHXQCMK-UHFFFAOYSA-N 0.000 description 1
- XMQKDVUPICPOSH-UHFFFAOYSA-N n-(2-chloro-6-methylphenyl)-2-[3-(hydroxymethyl)piperazin-1-yl]acetamide Chemical compound CC1=CC=CC(Cl)=C1NC(=O)CN1CC(CO)NCC1 XMQKDVUPICPOSH-UHFFFAOYSA-N 0.000 description 1
- QKKWUENYWLFYAC-UHFFFAOYSA-N n-(2-hydroxyethyl)piperazine-2-carboxamide Chemical compound OCCNC(=O)C1CNCCN1 QKKWUENYWLFYAC-UHFFFAOYSA-N 0.000 description 1
- ZPTBBFFYYDJPDQ-UHFFFAOYSA-N n-(4-acetyl-2,6-dichlorophenyl)-2-chloroacetamide Chemical compound CC(=O)C1=CC(Cl)=C(NC(=O)CCl)C(Cl)=C1 ZPTBBFFYYDJPDQ-UHFFFAOYSA-N 0.000 description 1
- KHVSHAFTQRJPOK-UHFFFAOYSA-N n-(4-amino-2,6-dimethylphenyl)-2-[4-[4,4-bis(4-fluorophenyl)butyl]-2-(hydroxymethyl)piperazin-1-yl]acetamide Chemical compound CC1=CC(N)=CC(C)=C1NC(=O)CN1C(CO)CN(CCCC(C=2C=CC(F)=CC=2)C=2C=CC(F)=CC=2)CC1 KHVSHAFTQRJPOK-UHFFFAOYSA-N 0.000 description 1
- LVDXRRWTJOFWCN-UHFFFAOYSA-N n-(4-amino-2-methylphenyl)-2-chloroacetamide Chemical compound CC1=CC(N)=CC=C1NC(=O)CCl LVDXRRWTJOFWCN-UHFFFAOYSA-N 0.000 description 1
- FVZXDKXFEPVJRE-UHFFFAOYSA-N n-(4-fluorophenyl)-4-methylbenzenesulfonamide Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NC1=CC=C(F)C=C1 FVZXDKXFEPVJRE-UHFFFAOYSA-N 0.000 description 1
- DUWWHGPELOTTOE-UHFFFAOYSA-N n-(5-chloro-2,4-dimethoxyphenyl)-3-oxobutanamide Chemical compound COC1=CC(OC)=C(NC(=O)CC(C)=O)C=C1Cl DUWWHGPELOTTOE-UHFFFAOYSA-N 0.000 description 1
- JIRUAMPMYJQDSO-UHFFFAOYSA-N n-(5-fluoro-2-methylphenyl)-2-[3-(hydroxymethyl)piperazin-1-yl]acetamide Chemical compound CC1=CC=C(F)C=C1NC(=O)CN1CC(CO)NCC1 JIRUAMPMYJQDSO-UHFFFAOYSA-N 0.000 description 1
- FLJJSULNLLNQTP-UHFFFAOYSA-N n-[bis(4-fluorophenyl)methyl]-2-chloroacetamide Chemical compound C1=CC(F)=CC=C1C(NC(=O)CCl)C1=CC=C(F)C=C1 FLJJSULNLLNQTP-UHFFFAOYSA-N 0.000 description 1
- LPOIGVZLNWEGJG-UHFFFAOYSA-N n-benzyl-5-(4-methylpiperazin-1-yl)-2-nitroaniline Chemical compound C1CN(C)CCN1C1=CC=C([N+]([O-])=O)C(NCC=2C=CC=CC=2)=C1 LPOIGVZLNWEGJG-UHFFFAOYSA-N 0.000 description 1
- VPMJTASZJZRIMH-UHFFFAOYSA-N n-methylpiperazine-2-carboxamide Chemical compound CNC(=O)C1CNCCN1 VPMJTASZJZRIMH-UHFFFAOYSA-N 0.000 description 1
- BQPORFHFPWJFIX-UHFFFAOYSA-N n-propan-2-ylpiperazine-2-carboxamide Chemical compound CC(C)NC(=O)C1CNCCN1 BQPORFHFPWJFIX-UHFFFAOYSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910000069 nitrogen hydride Inorganic materials 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 229940098462 oral drops Drugs 0.000 description 1
- 239000007968 orange flavor Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- WXWCDTXEKCVRRO-UHFFFAOYSA-N para-Cresidine Chemical compound COC1=CC=C(C)C=C1N WXWCDTXEKCVRRO-UHFFFAOYSA-N 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229960003424 phenylacetic acid Drugs 0.000 description 1
- LGRFSURHDFAFJT-UHFFFAOYSA-N phthalic anhydride Chemical compound C1=CC=C2C(=O)OC(=O)C2=C1 LGRFSURHDFAFJT-UHFFFAOYSA-N 0.000 description 1
- JSSXHAMIXJGYCS-UHFFFAOYSA-N piperazin-4-ium-2-carboxylate Chemical compound OC(=O)C1CNCCN1 JSSXHAMIXJGYCS-UHFFFAOYSA-N 0.000 description 1
- 229920006324 polyoxymethylene Polymers 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- GKKCIDNWFBPDBW-UHFFFAOYSA-M potassium cyanate Chemical compound [K]OC#N GKKCIDNWFBPDBW-UHFFFAOYSA-M 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- WYVAMUWZEOHJOQ-UHFFFAOYSA-N propionic anhydride Chemical compound CCC(=O)OC(=O)CC WYVAMUWZEOHJOQ-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000004089 psychotropic agent Substances 0.000 description 1
- 210000001147 pulmonary artery Anatomy 0.000 description 1
- 210000003492 pulmonary vein Anatomy 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000036387 respiratory rate Effects 0.000 description 1
- 210000005245 right atrium Anatomy 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 150000003335 secondary amines Chemical group 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910001923 silver oxide Inorganic materials 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 229960001462 sodium cyclamate Drugs 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 229960005137 succinic acid Drugs 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- DLFVBJFMPXGRIB-UHFFFAOYSA-N thioacetamide Natural products CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
- 235000012431 wafers Nutrition 0.000 description 1
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27662481A | 1981-06-23 | 1981-06-23 | |
| US276624 | 1981-06-23 | ||
| US362814 | 1982-03-29 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS584774A JPS584774A (ja) | 1983-01-11 |
| JPH0460988B2 true JPH0460988B2 (ko) | 1992-09-29 |
Family
ID=23057427
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP57104058A Granted JPS584774A (ja) | 1981-06-23 | 1982-06-18 | Ｎ−アリ−ル−ピペラジンアルカンアミド類 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPS584774A (ko) |
| ZA (1) | ZA824428B (ko) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3980885B2 (ja) * | 2000-02-22 | 2007-09-26 | スィーヴィー セラピューティクス インコーポレイテッド | 置換ピペラジン化合物 |
| CA2512261A1 (en) * | 2003-01-03 | 2004-07-29 | Cv Therapeutics, Inc. | Substituted heterocyclic compounds |
-
1982
- 1982-06-18 JP JP57104058A patent/JPS584774A/ja active Granted
- 1982-06-22 ZA ZA824428A patent/ZA824428B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA824428B (en) | 1984-02-29 |
| JPS584774A (ja) | 1983-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0068544B1 (en) | Novel n-aryl-piperazinealkanamides | |
| DE69615376T2 (de) | Piperazin-derivate als heilmittel | |
| US4666908A (en) | 5-Substituted pyrazolo[4,3-d]pyrimidine-7-ones and methods of use | |
| EP0079545B1 (en) | Benzimidazole derivatives, process for the preparation thereof and pharmaceutical composition containing the same | |
| CH649539A5 (de) | Antidepressiv wirksame piperazinylalkyl-1,2,4-triazol-3-one. | |
| JPH0517457A (ja) | ベンズイソチアゾールおよびベンズイソキサゾールピペラジン誘導体 | |
| JPS61246184A (ja) | ジアンヒドロヘキシツト誘導体、その製造方法およびその医薬としての用途 | |
| JP4166824B2 (ja) | ピペラジン誘導体および５−ｈｔ１ａ拮抗薬としてのそれらの使用 | |
| JPH0371410B2 (ko) | ||
| JP2574377B2 (ja) | 睡眠改善剤 | |
| JP2767321B2 (ja) | ピペラジン誘導体及びこれを含有する医薬 | |
| JPH10203986A (ja) | 眼疾患用薬剤 | |
| CA1244431A (en) | Phenylpiperazine derivatives and process for producing the same | |
| EP1210335A1 (de) | Aminocarbonyl-substituierte benzimidazolderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
| JPH0460988B2 (ko) | ||
| JP2823620B2 (ja) | ２−ヒドロキシ−３−フェノキシ−プロピル−置換ピペラジンないしはホモピペラジン | |
| JPS5838277A (ja) | スピロチアゾリジニルピペラジン誘導体 | |
| JPS62111970A (ja) | 置換された３−（４−フエニル−１−ピペラジニル）アルキルキナゾリン−２，４−（１ｈ，３ｈ）ジオン類 | |
| KR880000043B1 (ko) | Ｎ－아릴－피레라진알칸아미드의 제조법 | |
| JPH0517909B2 (ko) | ||
| US4716165A (en) | Histamine H1 antagonists | |
| JPH0351711B2 (ko) | ||
| JP2002504125A (ja) | ドーパミンｄ▲下４▼リガンドとしての２−アミノアルキルアミノキノリン | |
| JPH07119223B2 (ja) | ４−〔３−（４−オキソチアゾリジニル）〕ブチニルアミン類 | |
| JPH0345047B2 (ko) |